ENSYSCE BIOSCIENCES, INC. Cash and Cash Equivalents
ENSYSCE BIOSCIENCES, INC. (ENSC) had Cash and Cash Equivalents of $676.70 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $676.70K.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $745.48K.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $4.31M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.67M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $676.70K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $745.48K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.31M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.67M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.21M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.05M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $3.50M 10-K · filed 2026-03-30 |
| 2024-09-30 | $4.15M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.04M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $3.40M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.12M 10-K · filed 2025-03-10 |
| 2023-09-30 | $1.46M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.83M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.42M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.15M 10-K · filed 2024-03-15 |
| 2022-09-30 | $4.50M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.73M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $8.44M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $12.26M 10-K · filed 2023-03-30 |
| 2021-09-30 | $6.85M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $8.01M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $194.21K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |